Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression

NCT00186498 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: memantine
DRUG: Placebo Oral Capsule

Sponsor

Stanford University

Collaborators

[object Object]